Skip to main content

Media Category: x - Recorded Webinars

Generics and biosimilars in Multiple Sclerosis: understanding efficacy, safety and clinical confidence

Written by ParadigMS Foundation on .

Generics and biosimilars are becoming increasingly relevant in Multiple Sclerosis (MS) care as more follow-on treatments enter clinical practice. In this keynote, Thomas Berger explains how generics and biosimilars differ, how they are evaluated and approved, and why regulatory quality, bioequivalence, immunogenicity and pharmacovigilance are central to confidence in their use. Key Insights from the Lecture: Generics and biosimilars are already established in other areas of neurology, but their use in Multiple Sclerosis remains relatively recent. A major concern among both...

Continue reading

Multiple Sclerosis and pregnancy: balancing treatment, safety and family planning

Written by ParadigMS Foundation on .

Pregnancy and family planning remain important considerations in the management of Multiple Sclerosis (MS), particularly as treatment options become more effective and diverse. In this expert session, Thomas Berger reviews how different disease-modifying therapies (DMTs) can influence decisions before, during and after pregnancy, and highlights the importance of evidence-based counselling, individualized treatment planning and careful consideration of breastfeeding. Key Insights from the Lecture: Pregnancy itself is not presented as the main risk for women with Multiple Sclerosis;...

Continue reading

Central vein sign and paramagnetic rim lesions in Multiple Sclerosis diagnosis

Written by ParadigMS Foundation on .

New MRI biomarkers are becoming increasingly relevant in the diagnosis of Multiple Sclerosis (MS). Among them, the central vein sign (CVS) and paramagnetic rim lesions (PRLs) can improve diagnostic specificity and help distinguish MS from conditions that may mimic the disease. Šarlota Mesaroš reviews the biological basis, MRI detection and clinical relevance of these two biomarkers, and explains how they are incorporated into the revised McDonald diagnostic criteria. Key Insights from the Lecture: The central vein sign reflects a characteristic pathobiological feature of Multiple...

Continue reading

Radiologically Isolated Syndrome: from incidental findings to preclinical Multiple Sclerosis

Written by ParadigMS Foundation on .

Radiologically Isolated Syndrome (RIS) is becoming increasingly relevant as Multiple Sclerosis (MS) diagnosis moves from a purely clinical model toward a more biologically informed framework. In this keynote, Cecilia Rajda explores how the 2024 diagnostic criteria are reshaping the definition of RIS, which patients may now fulfil criteria for MS, and what this means for diagnostic work-up, follow-up, treatment decisions and communication with patients. Key Insights from the Lecture: Multiple Sclerosis may begin biologically before the first clinical symptoms appear. RIS describes...

Continue reading

Detecting progression in Multiple Sclerosis: practical approaches and emerging tools

Written by ParadigMS Foundation on .

Progression in Multiple Sclerosis (MS) can begin early and may continue even in the absence of relapses or new MRI lesions. Detecting these changes sooner is becoming increasingly relevant as new therapeutic options for progression emerge. In this keynote, Celia Oreja-Guevara explores how progression can be identified in clinical practice through a combination of patient-reported changes, functional assessment, cognition, MRI, optical coherence tomography (OCT), fluid biomarkers and digital tools. Key Insights from the Lecture: Progression can occur from the early stages of Multiple...

Continue reading

2024 McDonald Criteria: applying the new diagnostic framework in clinical practice

Written by ParadigMS Foundation on .

The 2024 revision of the McDonald Criteria introduces several important changes designed to support earlier and more accurate diagnosis of Multiple Sclerosis (MS). Mario Habek reviews how the revised criteria can be applied in clinical practice, including the incorporation of Radiologically Isolated Syndrome (RIS), the optic nerve as a fifth topography, kappa free light chains in cerebrospinal fluid analysis, and new MRI markers such as the central vein sign and paramagnetic rim lesions. Key Insights from the Lecture: Radiologically Isolated Syndrome can now meet diagnostic criteria...

Continue reading

FAQs

Is ParadigMS for free?

Yes, a ParadigMS subscription is free for healthcare practitioniers. 

Do subscriptions auto-renew?
Your subscription will automatically renew on yearly basis. If you cancel your plan, it will not renew at the end of your subscription cycle. 
I am a representative from industry, can I subscribe?

Free subscriptions to ParadigMS are reserved for healthcare practitioners. If you are a representative of the industry please contact us on learning@paradigms.foundation and we would advise you how to get the access to the material. 

What happens if I subscribe as a HCP if I am not?
If you subscribe as a healthcare practitioner and it is proven that you are not a healthcare practitioner, we will cancel your subscription immediately. 
I am a patient, can I subscribe?

ParadigMS is designed specifically for healthcare practitioners, with content and language tailored to their professional needs. While patients cannot subscribe directly, we encourage you to consult your healthcare provider for relevant insights and updates that may benefit you.

Why should I subscribe to ParadigMS's e-platform?

Subscribing to ParadigMS’s e-platform gives you access to up-to-date information and valuable learning materials on multiple sclerosis and NMO, along with expert insights and the latest innovations in the field. It’s an essential resource for staying informed and enhancing your knowledge in MS care.

How can I cancel my subscription?
You can cancel your subscription in your account settings. 
Can I financially support ParadigMS?

Yes, you can financially support ParadigMS! We welcome donations to help us continue our mission of advancing multiple sclerosis education and research. Your contribution directly supports the creation of educational resources, expert discussions, and innovative projects in MS care. Visit our donation page to learn more about how you can make a difference: ParadigMS Donate.